Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Levisonics is a manufacturer of blood coagulation devices created to perform non-contact analysis of blood coagulation.
Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.
PhagePro is an early-stage biotechnology therapeutics company.
Micro-Leads Medical is a medical technology company dedicated to developing innovative therapies that address the neuromodulation.
Pulvinar Neuro is to enable and support outstanding basic and translational neuroscience research.
Amygdala Neuroscience is a free online portal to create group projects and media item related to neuroscience.
Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies to reverse neurodegeneration.
Sparian Biosciences is a biopharmaceutical company.
Magnasense will create technology for biomarker assays that are easily accessible.
TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.
Enable Biosciences is a biotech company.
Aqualung Therapeutics is developing a novel, anti-inflammatory monoclonal antibody strategy to treat serious unchecked inflammation.
AcuraStem harnesses human, patient-specific in vitro cell models and assays to develop cures and improve diagnoses in disorders of the CNS.
Novel Microdevices is a medical device startup that develops a handheld point-of-care medical device to facilitate molecular diagnostics.
Lucid Diagnostics develops a non-invasive, office based diagnostic test for biomarkers to esophageal cancer.
Selsym Biotech is a biotechnology developer whose goal is to provide innovative platelet-mimetic therapies for the treatment.
Annoviant is a healthcare company that develops medical devices.
Oxalo Therapeutics creates drugs to treat rare kidney diseases and prevent recurring kidney stones.
InVivo Biosystems specializes in genome editing and preclinical research for neurological, metabolic, and rare monogenic diseases.
CareTaker Medical develops wireless medical devices for ICU-quality remote patient monitoring and continuous Blood Pressure
Oncospherix is the culmination of a multi-year research program for cancer.
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
Phase Genomics develops a biotechnology platform for new discoveries in agriculture, human health, and industrial biology industries.
GelSana Therapeutics develops novel advanced polymers to improve wound healing
National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Medical Device. The firm invests across 18 different industry categories.
Among tracked funding rounds, Allyx Therapeutics received $26.5M in a Series B round. National Institutes of Health's total known invested capital is $1.9B.
National Institutes of Health's average investment size is $4.9M across its portfolio of 491 companies.
Recent National Institutes of Health portfolio additions include Levisonics Inc, Nanopath, PhagePro, Micro-Leads, Pulvinar Neuro. These companies were founded in 2020 or later.